Novo Nordisk Canada Inc. is a global leader in the development of therapies for diabetes, metabolic diseases and blood disorders. Novo Nordisk’s innovations in diabetes cover both the treatment as well as devices, and we are working hard to find a cure for diabetes and, short of that, to completely reduce diabetes as an obstacle to a healthy and productive life.
Brian Hilberdink, President
Address:
2680 Skymark Avenue
Mississauga, ON L4W 5L6
Canada
Telephone number:
905-691-2208
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
Name | From | To |
---|---|---|
Novo Nordisk Canada Inc./ | 2024-04-01 | current |
Novo Nordisk Canada Inc./ | 2017-09-13 | 2024-04-01 |
Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
---|---|---|
Vince Lamanna | 2023-06-01 | Current |
Béatrice Clerc | 2019-09-19 | 2023-06-01 |
Brian Hilberdink | 2017-09-13 | 2019-09-17 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.